PYC 2.86% 18.0¢ pyc therapeutics limited

I really think this is a prelude to a take over - There last few...

  1. 511 Posts.
    lightbulb Created with Sketch. 32
    I really think this is a prelude to a take over - There last few ann have been puting all the info out ( i think )
    In one paragraph of this ann -

    More specifically, the Phylomer® drug candidates were shown to bind strongly to two
    RA disease targets that lie outside of the cell, including the classical target Tumour
    Necrosis Factor (TNF) and CD40 ligand.
    “Considering one of the current antibody drugs used to target TNF (Remicade -
    Johnson & Johnson) has annual sales of approximately $2.5 billion,

    Note - Anual sales of $2.5 billion , yes $2.5 billion !!
    And it is with Johnson & Johnson !!!!

    And pyc have millions of polymers to run against a magnitude of disease !!

    So its not just -
    burns
    strokes
    athriatis
    its blo#dy HEAPS more!!


    I dont think it will be long before it happens.

    YaHooooo

    Cheers
    Ag
 
watchlist Created with Sketch. Add PYC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.